Tylenol, Kleenex, Band-Aid and more put under one – Business News
Kimberly-Clark is shopping for Tylenol maker Kenvue in a money and stock deal price about $48.7 billion, creating a large shopper health items company.
Shareholders of Kimberly-Clark will own about 54% of the mixed company. Kenvue shareholders will own about 46%.
The mixed company may have a giant secure of family manufacturers under one roof, placing Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies, and Kleenex tissues. It may also generate about $32 billion in annual income.
Kimberly-Clark is shopping for Tylenol maker Kenvue in a money and stock deal price about $48.7 billion, creating a large shopper health items company. AP
Kenvue has spent a comparatively temporary period as an impartial company, having been spun off by Johnson & Johnson two years in the past. J&J first introduced in late 2021 that it was splitting its shopper health division from the pharmaceutical and medical system divisions.
The deal introduced Monday is among the many largest company takeovers of the 12 months.
Kenvue was thrust into the national highlight final month when Health Secretary Robert F. Kennedy, Jr. reasserted the unproven hyperlink between the ache reliever Tylenol and autism, and instructed people who opposed the speculation have been motivated by hatred for President Donald Trump.
During a assembly with Trump and the Cabinet, Kennedy reiterated the connection, even whereas noting there was no medical proof to substantiate the declare.
Shareholders of Kimberly-Clark will own about 54% of the mixed company. Kenvue shareholders will own about 46%. REUTERS
In July, Kenvue introduced that CEO Thibaut Mongon was leaving within the midst of a strategic review with the company under mounting stress from activist traders. Board member Kirk Perry is serving as interim CEO.
“We will serve billions of consumers across every stage of life,” Kimberly-Clark Chairman and CEO Mike Hsu stated in a assertion.
Hsu will probably be chairman and CEO of the mixed company. Three members of Kenvue’s board will be a part of Kimberly-Clark’s board at closing.
Kenvue was thrust into the national highlight final month when Health Secretary Robert F. Kennedy, Jr. reasserted the unproven hyperlink between the ache reliever Tylenol and autism. REUTERS
The mixed company will keep Kimberly-Clark’s headquarters in Irving, Texas, and proceed to have a important presence in Kenvue’s areas.
The deal is predicted to close within the second half of subsequent 12 months. It nonetheless wants approval from the shareholders of each corporations.
Kenvue shareholders will obtain $3.50 per share in money and 0.14625 Kimberly-Clark shares for every Kenvue share held at closing.
Kenvue shareholders will obtain $3.50 per share in money and 0.14625 Kimberly-Clark shares for every Kenvue share held at closing. REUTERS
That quantities to $21.01 per share, primarily based on the closing price of Kimberly-Clark shares on Friday.
Kimberly-Clark and Kenvue stated that they recognized about $1.9 billion in value financial savings which can be anticipated within the first three years after the transaction’s closing.
Shares of Kimberly-Clark slipped more than 15% earlier than the market opened, whereas Kenvue’s stock jumped more than 20%.
